Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
76 results
  1. MedlinePlus Drug Information: Atomoxetine 
    https://medlineplus.gov/druginfo/meds/a603013.html
    Atomoxetine is used as part of a total treatment program to increase the ability to pay attention ... and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective ...
  2. Appendices - Attention deficit hyperactivity disorder: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK553450
    ... Discontinuation due to adverse events at 7 weeks Atomoxetine versus placebo Figure 62 Quality of Life at ... Serious adverse events at 6 to 10 weeks Atomoxetine versus methylphenidate Figure 88 Quality of life (Child ...
  3. Appendices - Attention deficit hyperactivity disorder: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK553446
    ... versus non-pharmacological treatment E.1.1.1. Atomoxetine versus PT/FT Figure 1 ADHD symptoms (total, ... versus non-pharmacological treatment E.1.2.1. Atomoxetine + PT/FT versus PT/FT Figure 52 ADHD ...
  4. Cost-effectiveness analysis: Combination treatment in children and adolescents - Attention deficit hyperactivity ... 
    https://www.ncbi.nlm.nih.gov/books/NBK542665
    ... a more age appropriate therapy. 18 1.3. Atomoxetine combination model: Methods 1.3.1. Model overview ... review, for atomoxetine. Figure 1 Model 1 structure (Atomoxetine combination model) 1.3.2.2. Uncertainty The ...
  5. CLINICAL EVIDENCE –FOREST PLOTS - Autism - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK374178
    ... for overall autistic behaviours as an indirect outcome Atomoxetine versus placebo for overall autistic behaviours as an ... for behaviour that challenges as an indirect outcome Atomoxetine versus placebo for behaviour that challenges as an ...
  6. Findings - Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK327212
    ... weeks. All of the studies were industry sponsored. Atomoxetine A moderate risk of bias randomized, double-blind, ... taking other medications associated with NMS. 213 Nonstimulants Atomoxetine Overview Headache and anorexia were common side effects ...
  7. Placebo-Controlled Trials of Medications Used Off-Label or Those Under Investigation for Which We Found Only One Trial .... 
    https://www.ncbi.nlm.nih.gov/books/NBK208587
    ... 4.4 versus 5.5, p<0.001). Atomoxetine Characteristics of Trials Table E-2 summarizes characteristics ... in the U.S. and Canada. Investigators compared atomoxetine, titrated from 25 mg/day to 100 mg/ ...
  8. Treatment and management of binge eating disorder - Eating Disorders: Recognition and Treatment - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK533168
    ... placebo. 8.4.4.9. Other pharmacological interventions Atomoxetine (norepinephrine reuptake inhibitor) versus placebo in adults with ... evidence from one RCT (n=40) showed that atomoxetine is more effective on remission, BMI, weight loss, ...
  9. Results - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448267
    ... improved at all methylphenidate doses compared with placebo. Atomoxetine. Two RCTs of atomoxetine reported significant treatment-related ... 15 Harms/adverse effects in studies of methylphenidate. Atomoxetine. During the 8-week treatment versus placebo phase ...
  10. Excluded Studies - Interventions Targeting Sensory Challenges in Children With Autism Spectrum Disorder—An Update - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK448045
    ... Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled ... Journal Article. X-1, X-2 490. Favorable atomoxetine response in autism and ADHD. Brown University Child & ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next · last